Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tDCS and Varenicline for Tobacco Dependence
NCT03841292Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Oct 2018
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Center for Addiction and Mental Health. Primary endpoint: Change in smoking status over time at 26 weeks. Started Oct 2018; status: completed.
Beyond the preview
Go deeper on NCT03841292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03841292.